BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Diosynth Biotechnology (Morrisville) 

Executive Offices
101 J. Morris Commons Lane
Morrisville  North Carolina  27560  U.S.A.
Phone: 919-337-4477 or 866-762-6259
Fax: 919-337-0899


SEARCH JOBS


You Think It Up…We’ll Work It Out

Diosynth Biotechnology has a proven record in clinical & commercial cGMP contract manufacturing of complex recombinant proteins, vaccines, antibody derivatives, enzymes and fusion proteins.

We ensure our customers’ success by rapidly and cost effectively developing scalable, robust processes, applying our expertise with complex molecules, using a broad range of expression systems (Escherichia. coli, Pichia pastoris, Pfenex Expression Technology™, Saccharomyces, CHO, NS0, SP2/0, baculovirus (BEVS), etc.). Our global regulatory experience (FDA [CBER & CDER], EMEA, Health Canada; certified by JMHLW) with 80 different processes will assist you in determining what is relevant for your stage of product development.

Whether your product is in early stage development or you are preparing for BLA/MAA filing, Diosynth Biotechnology is committed to exceeding your expectations.

Diosynth Biotechnology is a part of Schering Plough Corporation.


 Key Statistics


Email: info@sp.diosynth.com
Ownership: Private

Web Site: Diosynth Biotechnology (Morrisville)
Employees: ~3,000
Symbol: 
 



Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
Selexis SA Announces License Renewal with Diosynth Biotechnology 8/2/2007 9:07:48 AM
Viron Therapeutics Inc. Signs Agreement With Diosynth Biotechnology For Clinical Manufacturing Of VT-111 10/25/2006 10:34:38 AM
Viron Therapeutics Inc. Signs Agreement With Diosynth Biotechnology For Clinical Manufacturing Of VT-111 10/24/2006 11:18:04 AM
Diosynth Biotechnology (Research Triangle Park) Announces Agreement With ImmunoGen, Inc. (IMGN)10/19/2005 5:13:18 PM
Pharming Group (PHGUF.PK) And Diosynth Biotechnology Sign Manufacturing Agreement For Rec. Human C1 Inhibitor10/19/2005 5:12:39 PM
BioSpace Releases Its 3rd Edition Of Bio NC™ 10/19/2005 5:12:33 PM
Vernalis PLC (VNLS) Signs Agreement With Diosynth Biotechnology (Research Triangle Park) For Phase III Manufacture Of V1015310/19/2005 5:12:29 PM
Diosynth Biotechnology (Research Triangle Park) Announces Amendment To Validation And Manufacturing Agreement With NeoPharm (NEOL) For IL13-PE38QQR10/19/2005 5:12:28 PM
Dendreon Corporation (DNDN) Achieves Commercial Scale Of Antigen For Provenge 10/19/2005 5:12:03 PM
Diosynth Biotechnology (Research Triangle Park) Is Selected By NeoPharm (NEOL) to Produce IL13-PE38QQR For An Important Phase III Trial10/19/2005 5:10:44 PM
12